These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Determination of uric acid in blood. Experimental determination; critical studies of the technics and results]. Cammeo F Quad Sclavo Diagn; 1971 Jun; 7(2):542-80. PubMed ID: 5152956 [No Abstract] [Full Text] [Related]
45. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Perez-Ruiz F; Lioté F Arthritis Rheum; 2007 Oct; 57(7):1324-8. PubMed ID: 17907217 [No Abstract] [Full Text] [Related]
46. [Features differentiating between gout and asymptomatic hyperuricemias. II. Laboratory data]. Gil Micharet MS; Bueno Jiménez C; Grau Linares V; Pérez Miranda M Rev Clin Esp; 1983 Sep; 170(6):279-82. PubMed ID: 6658070 [No Abstract] [Full Text] [Related]
47. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Tumgor G; Arikan C; Kilic M; Aydogdu S Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488 [TBL] [Abstract][Full Text] [Related]
48. [Diet therapy of gout and urate nephrolithiasis]. Gröbner W Internist (Berl); 1984 May; 25(5):287-91. PubMed ID: 6376409 [No Abstract] [Full Text] [Related]
49. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
50. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. Lin KC; Tsao HM; Chen CH; Chou P J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929 [TBL] [Abstract][Full Text] [Related]
51. [Hyperuricemia]. De Biasio R ZFA (Stuttgart); 1976 Feb; 52(4):188-9. PubMed ID: 1266327 [No Abstract] [Full Text] [Related]
52. Gout and serum cholesterol. BECKER JH Wis Med J; 1960 Dec; 59():735-7. PubMed ID: 13688460 [No Abstract] [Full Text] [Related]
54. [Value of uric acid clearance for the differential diagnosis and differential therapy of disorders of uric acid metabolism]. Schröder HE; Heinrich JJ Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 78-80. PubMed ID: 7467590 [No Abstract] [Full Text] [Related]
58. Hyperuricemia and gout: new insights into pathogenesis and treatment. Pillinger MH; Rosenthal P; Abeles AM Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673 [TBL] [Abstract][Full Text] [Related]
59. Confounders of uric acid levels. Kuo SC; Yang YH Arch Intern Med; 2005 May; 165(9):1071. PubMed ID: 15883254 [No Abstract] [Full Text] [Related]
60. Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout. Reynolds PP; Knapp MJ; Baraf HS; Holmes EW Arthritis Rheum; 1983 Sep; 26(9):1057-64. PubMed ID: 6412722 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]